{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-1976-N-0476\" and posted_year = 2019 sorted by posted_date descending", "rows": [["FDA-1976-N-0476-0369", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Ross Herr (The Upjohn Company) and Dr. P. D. Lepore (FDA), dated 08/10/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:23:44Z", null, 0, 0, "0900006480521a72"], ["FDA-1976-N-0476-0595", "FDA", "FDA-1976-N-0476", "Internal Memorandum from Staff Scientist Bioresearch Monitoring Staff (HFC-30) to Dockets Management Branch (HFA-305), October 06, 1981", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:21:22Z", null, 0, 0, "0900006480521b3d"], ["FDA-1976-N-0476-0284", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Dr. John Farnham, American Cyanamid Company and Dr. Carl Schulz, FDA/BVM, dated 10/04/1978", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:41:11Z", null, 0, 0, "0900006480521a1f"], ["FDA-1976-N-0476-0275", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Dr. Ir. P. van der Wal, ILOB and Drs. M. A. Norcross and P. D. Lepore, FDA/BVM, dated 12/16/1977", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:37:27Z", null, 0, 0, "0900006480521a17"], ["FDA-1976-N-0476-0316", "FDA", "FDA-1976-N-0476", "Letter from National Association of Life Science Industries to FDA CVM", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:12:26Z", null, 0, 0, "0900006480521a3e"], ["FDA-1976-N-0476-0266", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. O. D. Butler and Dr. P. D. Lepore, FDA/BVM, dated 08/08/1977", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:29:46Z", null, 0, 0, "0900006480521a10"], ["FDA-1976-N-0476-0323", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between The Upjohn Company and FDA/BVM, dated 03/13/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:15:55Z", null, 0, 0, "0900006480521a44"], ["FDA-1976-N-0476-0432", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Walter Gakenheimer (ICI America) and Dr. P. D. Lepore (FDA), dated 12/19/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T19:05:28Z", null, 0, 0, "0900006480521aaa"], ["FDA-1976-N-0476-0404", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between The Upjohn Company and FDA, dated 10/16/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:54:27Z", null, 0, 0, "0900006480521a90"], ["FDA-1976-N-0476-0394", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Patsy Marks (Dawson Laboratories) and Dr. Paul D. Lepore (FDA), dated 10/02/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:47:23Z", null, 0, 0, "0900006480521a88"], ["FDA-1976-N-0476-0370", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Lowell Irminger (Adria) and Dr. P. D. Lepore (FDA), dated 08/29/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:23:45Z", null, 0, 0, "0900006480521a73"], ["FDA-1976-N-0476-0399", "FDA", "FDA-1976-N-0476", "Answer Letter from FDA to Xybion Medical Systems Corporation", "Other", "Answer", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:47:45Z", null, 0, 0, "0900006483787852"], ["FDA-1976-N-0476-0425", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Candy Prejean (Southern Research Institute) and Dr. Paul D. Lepore (FDA), dated 11/30/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:59:47Z", null, 0, 0, "0900006480521aa4"], ["FDA-1976-N-0476-0452", "FDA", "FDA-1976-N-0476", "Answer Letter from FDA to EG&G Mason Research Institute", "Other", "Answer", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:12:47Z", null, 0, 0, "090000648378c68f"], ["FDA-1976-N-0476-0527", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. William Gray (Schering Corporation) and Dr. P. D. Lepore (FDA/ORA) May 8 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:47:55Z", null, 0, 0, "0900006480521b03"], ["FDA-1976-N-0476-0560", "FDA", "FDA-1976-N-0476", "Answer Letter from Dr. Paul D. Lepore, FDA to Robert S Gold, Metpath Inc", "Other", "Answer", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:59:28Z", null, 0, 0, "09000064837964ca"], ["FDA-1976-N-0476-0555", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Patricia Richards (Fisonf Corporation) and Frank G. Pugliese (FDA/BVM), dated July 17 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:56:26Z", null, 0, 0, "0900006480521b1c"], ["FDA-1976-N-0476-0561", "FDA", "FDA-1976-N-0476", "Letter from Jean M Taylor, FDA to Ann Smith, Allied Chemical Company", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:00:08Z", null, 0, 0, "0900006480521b21"], ["FDA-1976-N-0476-0528", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Donald Howard (G. D. Searle and Company) and Dr. P. D. Lepore (FDA/ORA), dated 05/12/1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:47:56Z", null, 0, 0, "0900006480521b04"], ["FDA-1976-N-0476-0601", "FDA", "FDA-1976-N-0476", "Good Laboratory Practices for Nonclinical Laboratory Studies; Public Hearing", "Notice", "Hearings", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", "1977-01-16T04:59:59Z", "2019-01-30T21:21:54Z", "76-36566", 0, 0, "0900006480521b42"], ["FDA-1976-N-0476-0563", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Fred Clark (A. H. Robins) and Dr. Paul D. Lepore (FDA/ORA) August 28 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:01:20Z", null, 0, 0, "0900006480521b23"], ["FDA-1976-N-0476-0568", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Paul Gittleson (Bristol Labs) and Dr. Paul D. Lepore (FDA/ORA) October 28 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:02:43Z", null, 0, 0, "0900006480521b27"], ["FDA-1976-N-0476-0503", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Nelson Ivans (Carter-Wallace Labs) and Dr. Paul D. Lepore (FDA/ORA), dated 03/19/1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:36:54Z", null, 0, 0, "0900006480521aec"], ["FDA-1976-N-0476-0504", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between R. Holecek (Shell Development Corporation) and Dr. P. D. Lepore (FDA/ORA), dated 03/18/1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:36:55Z", null, 0, 0, "0900006480521aed"], ["FDA-1976-N-0476-0483", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Virgil Place (Alza Corp) and Beth Anne Grove (FDA/BVM), dated 01/24/1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:29:13Z", null, 0, 0, "0900006480521ad9"], ["FDA-1976-N-0476-0524", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Don MacKellor (Toxigenics, Inc.) and Dr. P. D. Lepore (FDA/ORA) April 18 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:45:04Z", null, 0, 0, "0900006480521b01"], ["FDA-1976-N-0476-0419", "FDA", "FDA-1976-N-0476", "Internal Memorandum from Steven S. Kuwahara, Bureau of Disease Control and Laboratory Services State of Michigan and Paul W. Goebel, Jr. (HFB-730) November 1, 1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:59:40Z", null, 0, 0, "0900006480521a9e"], ["FDA-1976-N-0476-0373", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Max Moeller (Bayvet Corporation) and Dr. Paul Lepore (FDA), dated 08/30/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:32:37Z", null, 0, 0, "0900006480521a75"], ["FDA-1976-N-0476-0351", "FDA", "FDA-1976-N-0476", "Petition for Stay of Action from The Pharmaceutical Manufacturers Association", "Other", "Petition for Reconsideration", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T17:55:05Z", null, 0, 0, "0900006480521a61"], ["FDA-1976-N-0476-0352", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. W. Gakenheimer, ICI Americas and Dr. Paul D. Lepore, FDA dated 06/21/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T17:55:06Z", null, 0, 0, "0900006480521a62"], ["FDA-1976-N-0476-0360", "FDA", "FDA-1976-N-0476", "Answer Letter from FDA to Objection from Dennis McKay", "Other", "Answer", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:14:33Z", null, 0, 0, "0900006483785c91"], ["FDA-1976-N-0476-0303", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. T. S. Grafton, Natl. Soc. for Med. Research and Dr. P. D. Lepore, FDA/BVM dated 01/04/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:54:28Z", null, 0, 0, "0900006480521a32"], ["FDA-1976-N-0476-0307", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Leroy Schilt, Ralston Purina and Dr. P. D. Lepore, FDA/BVM dated 01/18/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:00:20Z", null, 0, 0, "0900006480521a36"], ["FDA-1976-N-0476-0321", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Drs. H. M. Peck and R. T. Drew, Merck Sharp & Dohme and Drs. D. Wagner and P. D. Lepore, FDA/BVM dated 03/08/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:15:52Z", null, 0, 0, "0900006480521a42"], ["FDA-1976-N-0476-0319", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Ralston Purina Co. and FDA/BVM, dated 02/07/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:15:49Z", null, 0, 0, "0900006480521a40"], ["FDA-1976-N-0476-0333", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Cynthia Sargent, Lederle Labs and Dr. P. D. Lepore, FDA dated 04/28/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T17:43:40Z", null, 0, 0, "0900006480521a4f"], ["FDA-1976-N-0476-0480", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Don McKuellar (Toxigenics, Inc) and Dr. P. D. Lepore (FDA/ORA), dated 01/30/1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:25:22Z", null, 0, 0, "0900006480521ad6"], ["FDA-1976-N-0476-0556", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Sheldon Mazursky (Litton Bionetics) and Dr. Paul D. Lepore (FDA/ORA) July 25 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:56:27Z", null, 0, 0, "0900006480521b1d"], ["FDA-1976-N-0476-0502", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Julian Kramer and Dr. Paul D. Lepore (FDA/ORA), dated 03/19/1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:36:53Z", null, 0, 0, "0900006480521aeb"], ["FDA-1976-N-0476-0469", "FDA", "FDA-1976-N-0476", "Supplement from Pharmaceutical Manufacturers Association", "Other", "Supplement (SUP)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:25:11Z", null, 0, 0, "0900006480521aca"], ["FDA-1976-N-0476-0574", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Jim Schaefer (Elars Bioresearch) and Dr. Paul D. Lepore (FDA) December 22 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:02:50Z", null, 0, 0, "0900006480521b2d"], ["FDA-1976-N-0476-0564", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between The Upjohn Company and FDA/ORA September 17 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:01:21Z", null, 0, 0, "0900006480521b24"], ["FDA-1976-N-0476-0565", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Jonas Bassen and Dr. P. D. Lepore (FDA/ORA) October 7 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:01:22Z", null, 0, 0, "0900006480521b25"], ["FDA-1976-N-0476-0341", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. M. Lovell, Lederle Laboratories and Dr. P. D. Lepore, FDA dated 05/22/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T17:45:43Z", null, 0, 0, "0900006480521a57"], ["FDA-1976-N-0476-0602", "FDA", "FDA-1976-N-0476", "Good Laboratory Practices for Nonclinical laboratory Studies, Public Hearing Extension", "Notice", "Hearings", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2020-01-31T06:56:46Z", "77-3217", 0, 0, "0900006483786fa1"], ["FDA-1976-N-0476-0291", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Mr. Sheldon Mazursky, Litton Bionetics and Dr. David D. Wagner, FDA/BVM dated 01/15/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:42:57Z", null, 0, 0, "0900006480521a26"], ["FDA-1976-N-0476-0273", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between A. Fozard and A. Nelms, Mount Industrial Estate and M. A. Norcross and P. D. Lepore FDA/BVM dated 11/11/1977", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:35:45Z", null, 0, 0, "0900006480521a15"], ["FDA-1976-N-0476-0279", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Dr. Benjamin H. Franklin, Dow Corning Corporation and Dr. Carl O Schulz, FDA/BVM, dated 06/01/1978", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:39:51Z", null, 0, 0, "0900006480521a1a"], ["FDA-1976-N-0476-0280", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Dr. George Schuppler, Dept. of Experimental Toxicology, and Drs. Paul Lepore et. al. FDA/BVM, dated 05/17/1978", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:39:52Z", null, 0, 0, "0900006480521a1b"], ["FDA-1976-N-0476-0309", "FDA", "FDA-1976-N-0476", "Answer Letter from FDA to Objection from Dr. Travis Griffin", "Other", "Answer", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:00:28Z", null, 0, 0, "090000648377a46e"], ["FDA-1976-N-0476-0312", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Alan Hirsh, Ortho Pharmaceutical Corp. and Dr. P. D. Lepore, FDA/BVM dated 01/26/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:12:22Z", null, 0, 0, "0900006480521a3a"], ["FDA-1976-N-0476-0302", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Ms. Marion Vinegar, Hilltop Research and Dr. P. D. Lepore, FDA/BVM dated 01/04/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:54:27Z", null, 0, 0, "0900006480521a31"], ["FDA-1976-N-0476-0249", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Richard Morey, Kleinfeld, Kaplan, and Becker and Howard R. Roberts, FDA dated 04/12/1977", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:23:32Z", null, 0, 0, "0900006480521a02"], ["FDA-1976-N-0476-0324", "FDA", "FDA-1976-N-0476", "Nonclinical Laboratory Studies, Good Laboratory Practice Regulations; Correction", "Rule", "Correction", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:15:55Z", "79-9094", 0, 0, "0900006480521a45"], ["FDA-1976-N-0476-0322", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between T. J. Fogg, Shell and Dr. P. D. Lepore, FDA/BVM dated 03/12/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:15:53Z", null, 0, 0, "0900006480521a43"], ["FDA-1976-N-0476-0429", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Eva Zurek (Hazleton Laboratories) and Dr. P. D. Lepore (FDA), dated 12/11/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T19:02:08Z", null, 0, 0, "0900006480521aa7"], ["FDA-1976-N-0476-0363", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. R. Drew (Merck & Company) and Dr. P. D. Lepore (FDA), dated 08/03/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:18:32Z", null, 0, 0, "0900006480521a6c"], ["FDA-1976-N-0476-0401", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Nona Karten (Mason Research Institute) and Dr. P. D. Lepore (FDA), dated 10/11/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:52:30Z", null, 0, 0, "0900006480521a8d"], ["FDA-1976-N-0476-0248", "FDA", "FDA-1976-N-0476", "Answer Letter from FDA to Comment from Honorable Wendell R. Anderson, United States Senate", "Other", "Answer", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:14:01Z", null, 0, 0, "090000648374730d"], ["FDA-1976-N-0476-0539", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Hall Moore (Burroughs-Wellcome) and Dr. P. D. Lepore (FDA/ORA) May 30 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:50:13Z", null, 0, 0, "0900006480521b0e"], ["FDA-1976-N-0476-0590", "FDA", "FDA-1976-N-0476", "Answer Letter from FDA to Bundesverband Der Pharmazeutischen Industrie E. V.", "Other", "Answer", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:12:10Z", null, 0, 0, "09000064837998a2"], ["FDA-1976-N-0476-0598", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between The Upjohn Company and FDA/ORA February 22 1982", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:21:25Z", null, 0, 0, "0900006480521b40"], ["FDA-1976-N-0476-0576", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Dr. Thomas W. Orme (Toxicology Paperwork and Information, Inc.) and Dr. Paul D. Lepore (FDA) February 10 1981", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:02:52Z", null, 0, 0, "0900006480521b2f"], ["FDA-1976-N-0476-0505", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Art Uelner (Monsanto Corporation) and Dr. P. D. Lepore (FDA/ORA), dated 03/21/1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:36:56Z", null, 0, 0, "0900006480521aee"], ["FDA-1976-N-0476-0345", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. E. C. Sadero, Intermedics and Dr. P. D. Lepore, FDA dated 06/05/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T17:45:47Z", null, 0, 0, "0900006480521a5b"], ["FDA-1976-N-0476-0338", "FDA", "FDA-1976-N-0476", "Internal Memorandum from Biological Scientist, Bioresearch Monitoring Staff (HFC-30) to Director Division of Field Investigations (HF0-500) May 21, 1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T17:45:40Z", null, 0, 0, "0900006480521a54"], ["FDA-1976-N-0476-0254", "FDA", "FDA-1976-N-0476", "Memorandum from James A. Peters, Division of Cancer Cause & Prevention, NCI to Associate Commissioner for Science, FDA", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:26:43Z", null, 0, 0, "0900006480521a06"], ["FDA-1976-N-0476-0311", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Ms. Laurie Ennis, Seller, Conner, & Cuneo and Dr. P. D. Lepore, FDA/BVM dated 01/29/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:12:21Z", null, 0, 0, "0900006480521a39"], ["FDA-1976-N-0476-0310", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Mr. Mike Hurley, Ayerst Laboratories and Dr. P. D. Lepore, FDA/BVM dated 01/23/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:12:20Z", null, 0, 0, "0900006480521a38"], ["FDA-1976-N-0476-0331", "FDA", "FDA-1976-N-0476", "Good Laboratory Practices Management Conferences Public Meeting", "Notice", "General Notice", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T17:41:31Z", null, 0, 0, "0900006480521a4b"], ["FDA-1976-N-0476-0551", "FDA", "FDA-1976-N-0476", "Letter from Nadine Drennan, Sanitation Laboratories to Paul D. Lepore, FDA", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:54:18Z", null, 0, 0, "0900006480521b19"], ["FDA-1976-N-0476-0535", "FDA", "FDA-1976-N-0476", "Letter from Ernest Brisson, FDA to Jose C. March, Guerlain, Inc.", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:49:00Z", null, 0, 0, "0900006480521b0b"], ["FDA-1976-N-0476-0523", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between ICI America and FDA/ORA April 18 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:45:03Z", null, 0, 0, "0900006480521b00"], ["FDA-1976-N-0476-0546", "FDA", "FDA-1976-N-0476", "Answer Letter from FDA to H. Lundbeck & Co.", "Other", "Answer", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:52:11Z", null, 0, 0, "09000064837953e4"], ["FDA-1976-N-0476-0493", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. William D. Grey (Schering-Plough Corporation) and Dr. Paul D. Lepore (FDA/ORA), dated 02/25/1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:36:45Z", null, 0, 0, "0900006480521ae2"], ["FDA-1976-N-0476-0497", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Lee Caldwell (G. D. Searle & Co.) and Dr. P. D. Lepore (FDA/ORA) dated 03/03/1980 and 03/04/1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:36:49Z", null, 0, 0, "0900006480521ae6"], ["FDA-1976-N-0476-0562", "FDA", "FDA-1976-N-0476", "Letter from Dr. Paul D. Lepore to John J Gagliardi", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:01:19Z", null, 0, 0, "0900006480521b22"], ["FDA-1976-N-0476-0592", "FDA", "FDA-1976-N-0476", "Internal Memorandum from Bioresearch Monitoring Staff (HFC-30) to Dockets Management Branch (HFA-305) June 19, 1981", "Supporting & Related Material", "Reference (internal unless indicated)", "2019-01-30T05:00:00Z", 2019, 1, null, null, "2019-01-30T21:12:48Z", null, 0, 0, "0900006480521b3a"], ["FDA-1976-N-0476-0400", "FDA", "FDA-1976-N-0476", "Answer from FDA to Letter from American Cyanimid Company", "Other", "Answer", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:49:36Z", null, 0, 0, "090000648378567d"], ["FDA-1976-N-0476-0412", "FDA", "FDA-1976-N-0476", "Letter from Larry S. Isacson of Beckman Instruments, Inc. to Paul Lepore of FDA", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:56:26Z", null, 0, 0, "0900006480521a98"], ["FDA-1976-N-0476-0423", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Candy Prejean (Southern Research Institute) and Dr. P. D. Lepore (FDA), dated 11/28/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:59:45Z", null, 0, 0, "0900006480521aa2"], ["FDA-1976-N-0476-0417", "FDA", "FDA-1976-N-0476", "Letter from Carnegie-Mellon Institute of Research to FDA", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:58:23Z", null, 0, 0, "0900006480521a9c"], ["FDA-1976-N-0476-0377", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Nelson Ivins (09/07/1979) and Dr. P. D. Lepore (FDA), dated 09/07/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:32:40Z", null, 0, 0, "0900006480521a79"], ["FDA-1976-N-0476-0375", "FDA", "FDA-1976-N-0476", "Letter from FDA to Borriston Research Laboratories", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:32:39Z", null, 0, 0, "0900006480521a77"], ["FDA-1976-N-0476-0371", "FDA", "FDA-1976-N-0476", "Letter from Microscopy for Biological Research, Ltd. to FDA", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:23:46Z", null, 0, 0, "0900006480521a74"], ["FDA-1976-N-0476-0361", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Charles Rayner (Miles Laboratories) and Dr. P. D. Lepore (FDA), dated 07/12/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T18:18:30Z", null, 0, 0, "0900006480521a6a"], ["FDA-1976-N-0476-0451", "FDA", "FDA-1976-N-0476", "Letter from EG. and G. Mason Research Institute to FDA", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:10:00Z", null, 0, 0, "0900006480521aba"], ["FDA-1976-N-0476-0437", "FDA", "FDA-1976-N-0476", "Letter from Paul D. Lepore, FDA to Robert Broyles, Ralston-Purina Company", "Other", "Letter(s)", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T19:07:11Z", null, 0, 0, "0900006480521aae"], ["FDA-1976-N-0476-0257", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Drs. Sanford Berman and Dr. Howard Lowensohn, Walter Reed Institute of Research and Dr. P. D. Lepore FDA/CVM dated 06/16/1977", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:26:46Z", null, 0, 0, "0900006480521a09"], ["FDA-1976-N-0476-0265", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting Between ICI USA, ICI UK and FDA BVM, dated 07/07/1977", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:29:45Z", null, 0, 0, "0900006480521a0f"], ["FDA-1976-N-0476-0288", "FDA", "FDA-1976-N-0476", "Memorandum from Paul D. Lepore, FDA/BVM to Dr. L. Schilt, Ralston Purina", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:42:55Z", null, 0, 0, "0900006480521a23"], ["FDA-1976-N-0476-0269", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Dr. Erwig Pinter, BPI and Drs. Paul D. Lepore and Carl O. Schulz FDA/BVM, dated 09/20/1977", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:31:49Z", null, 0, 0, "0900006480521a12"], ["FDA-1976-N-0476-0298", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Paul Kraus, Allergan and Dr. P. D. Lepore, FDA/BVM dated 01/03/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:54:22Z", null, 0, 0, "0900006480521a2d"], ["FDA-1976-N-0476-0294", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Mr. Mike McCulley, Am. Hospital Supply Company and Dr. P. D. Lepore, FDA/BVM dated 01/05/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:43:00Z", null, 0, 0, "0900006480521a29"], ["FDA-1976-N-0476-0315", "FDA", "FDA-1976-N-0476", "Memorandum of Meeting between Allied Mills, Inc. and FDA/BVM dated 02/16/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T15:12:25Z", null, 0, 0, "0900006480521a3d"], ["FDA-1976-N-0476-0289", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Mr. Sheldon Mazursky, Litton Bionetics and Dr. David Wagner, FDA/BVM dated 01/08/1979", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T14:42:56Z", null, 0, 0, "0900006480521a24"], ["FDA-1976-N-0476-0594", "FDA", "FDA-1976-N-0476", "Internal Memorandum from Dr. Paul D. Lepore (HFC-30) to Dockets Management Branch (HFA-305), August 14,1981", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T21:21:21Z", null, 0, 0, "0900006480521b3c"], ["FDA-1976-N-0476-0487", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Dr. Jim Richmond (Ciba-Geigy) and Dr. Paul D. Lepore (FDA/ORA), dated 02/07/1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:29:16Z", null, 0, 0, "0900006480521add"], ["FDA-1976-N-0476-0552", "FDA", "FDA-1976-N-0476", "Answer Letter from Paul D. Lepore, FDA to Nadine Drennan, Sanitation Laboratories", "Other", "Answer", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:55:00Z", null, 0, 0, "0900006483795bec"], ["FDA-1976-N-0476-0518", "FDA", "FDA-1976-N-0476", "Memorandum of Telephone Conversation between Huntingdon Research Centre and FAD/ORA April 28 1980", "Other", "Memorandum", "2019-01-30T05:00:00Z", 2019, 1, "2019-01-30T05:00:00Z", null, "2019-01-30T20:44:59Z", null, 0, 0, "0900006480521afb"]], "truncated": false, "filtered_table_rows_count": 382, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-1976-N-0476", "p1": "2019"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019", "results": [{"value": "FDA", "label": "FDA", "count": 382, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019", "results": [{"value": "Other", "label": "Other", "count": 357, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&document_type=Notice", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019", "results": [{"value": 2019, "label": 2019, "count": 382, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&_facet=posted_date"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&_facet=comment_end_date"}, {"name": "fr_doc_num", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&_facet=fr_doc_num"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&_facet_date=last_modified"}], "next": "2019-01-30T05~3A00~3A00Z,FDA-1976-N-0476-0518", "next_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1976-N-0476&posted_year=2019&_next=2019-01-30T05~3A00~3A00Z%2CFDA-1976-N-0476-0518&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1112.1863609878346, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}